Amanda Feilding, Countess of Wemyss and March, has dedicated the past 50 years to the scientific exploration of consciousness and its altered states. She has a particular interest in the potential therapeutic benefits of psychedelics, such as LSD. Feilding, a self-taught scientist, has been instrumental in bringing about a renaissance in psychedelic research, which was largely stigmatised and restricted since the 1960s.

In recent years, Feilding’s efforts have resulted in significant breakthroughs. Studies have shown that psychedelics can effectively treat various mental health conditions, including depression and anxiety. A significant discovery was that psilocybin, found in magic mushrooms, could reset the brains of people with untreatable depression.

Feilding’s research has faced criticism and resistance, particularly from those who fear the recreational misuse of psychedelics. However, she remains undeterred, believing in the potential of these substances to revolutionise mental health treatment. She emphasises the importance of regulation and controlled environments in the therapeutic use of psychedelics.

Feilding’s work has also led to the establishment of the Beckley Foundation, which collaborates with leading scientists worldwide to further psychedelic research. The foundation has been pivotal in changing attitudes towards these substances, encouraging a shift from fear and stigmatisation to understanding and acceptance.

Go to source article: